LASP1 and breast cancer: LASP1 overexpression in breast cancer was confirmed by immunohistochemistry (IHC), using an immunoreactivity score, a semi-quantitative rating for cell staining: The score was significantly higher in invasive breast carcinomas compared to mammary fibroadenomas.